Tilray Inc (NASDAQ:TLRY - Get Free Report)'s stock price rose 0.8% during mid-day trading on Wednesday . The company traded as high as $0.49 and last traded at $0.46. Approximately 7,614,100 shares changed hands during mid-day trading, a decline of 74% from the average daily volume of 29,280,333 shares. The stock had previously closed at $0.46.
Analyst Upgrades and Downgrades
Several equities analysts have commented on TLRY shares. Piper Sandler lowered their price objective on shares of Tilray from $2.00 to $1.00 and set a "neutral" rating for the company in a research report on Wednesday, April 9th. Canaccord Genuity Group lifted their price target on Tilray from $2.00 to $3.00 and gave the stock a "buy" rating in a research report on Monday, January 13th. Finally, Roth Capital reaffirmed a "neutral" rating on shares of Tilray in a research note on Monday, April 14th.
Read Our Latest Research Report on Tilray
Tilray Price Performance
The stock's 50-day moving average is $0.63 and its two-hundred day moving average is $1.10. The company has a market capitalization of $498.22 million, a PE ratio of -1.65 and a beta of 1.88. The company has a current ratio of 2.54, a quick ratio of 1.58 and a debt-to-equity ratio of 0.10.
Tilray (NASDAQ:TLRY - Get Free Report) last posted its quarterly earnings data on Tuesday, April 8th. The company reported ($0.10) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.04) by ($0.06). Tilray had a negative net margin of 30.95% and a negative return on equity of 4.40%. The business had revenue of $185.78 million for the quarter, compared to analysts' expectations of $213.38 million. On average, equities analysts predict that Tilray Inc will post -0.2 EPS for the current year.
Institutional Investors Weigh In On Tilray
A number of institutional investors and hedge funds have recently added to or reduced their stakes in TLRY. Lido Advisors LLC purchased a new position in shares of Tilray during the fourth quarter worth approximately $28,000. Dudley Capital Management LLC bought a new stake in Tilray during the 4th quarter valued at $29,000. Verdence Capital Advisors LLC purchased a new stake in shares of Tilray in the 4th quarter worth $29,000. Ameritas Advisory Services LLC bought a new position in shares of Tilray during the 4th quarter worth $32,000. Finally, Newman Dignan & Sheerar Inc. increased its stake in shares of Tilray by 61.9% during the fourth quarter. Newman Dignan & Sheerar Inc. now owns 26,150 shares of the company's stock valued at $35,000 after buying an additional 10,000 shares during the period. Institutional investors own 9.35% of the company's stock.
Tilray Company Profile
(
Get Free Report)
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.
Read More
Before you consider Tilray, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tilray wasn't on the list.
While Tilray currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
